Simple Summary
Feline herpesvirus type 1 (FHV-1) is a highly contagious pathogen that causes upper respiratory tract and ocular disease in domestic cats and also threatens captive and wild felids, including tigers, lions, and cheetahs. Currently, feline viral Rhinotracheitis-Calicivirus-Panleukopenia (FRCP) live vaccine remains the most widely used and effective strategy for controlling FHV-1 infection. However, post-vaccination viral shedding and the establishment of latent infection can interfere with the clinical diagnosis of field strain infection, and currently available diagnostic assays cannot distinguish FHV-1 live vaccine from field strains. To address this limitation, we developed a duplex qPCR assay for the simultaneous detection and differential diagnosis of FHV-1 F2-associated strains (including FHV-1 live vaccine) and other strains. This assay is rapid, cost-effective, specific, sensitive, and reproducible, and can accurately determine the F2-associated allele, providing a viable diagnostic tool to distinguish the FHV-1 F2 vaccine strain from field isolates when combined with definitive vaccination history and epidemiological information.
Abstract
Feline herpesvirus-1 (FHV-1) is an important pathogen causing feline upper respiratory tract disease and poses a serious threat to the health of domestic cats as well as captive and wild felids. Vaccination remains a crucial strategy for controlling FHV-1 infection. Feline trivalent live vaccines are the most widely used and effective products, and all use the FHV-1 F2 strain as the vaccine component. However, no diagnostic method is currently available to distinguish F2 vaccine strains from other FHV-1 strains. In this study, we targeted the A397G SNP in the UL44 gene and developed a MGB probe-based duplex allele-specific qPCR for simultaneous detection and differential diagnosis of FHV-1 F2-associated strains and non-F2 strains. This assay showed no cross-reactivity with other major feline pathogens or heterologous animal herpesviruses. The 95% limit of detection (LOD) was 11.5 copies/μL for FHV-1 F2-associated strains and 4.33 copies/μL for non-F2 strains. Intra- and inter-assay coefficients of variation were both below 2.5%. Evaluation using clinical samples and a blinded simulated-panel confirmed that this assay could accurately determine F2-associated allele. In conclusion, this assay is a rapid, specific, sensitive, and viable diagnostic tool to distinguish the FHV-1 F2 vaccine strain from field isolates, in conjunction with definitive vaccination history and epidemiological information.